Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Low-density platelet populations demonstrate low<i>in vivo</i>activity in sporadic Alzheimer disease

13 Dec 2011

Abstract excerpt

Platelets contain a substantial quantity of amyloid-precursor protein (APP) and β-amyloid. However, despite the large importance of APP and β-amyloid to dementia, little is known about platelets in sporadic Alzheimer dementia (AD). Furthermore, platelet heterogeneity influences human pathology and has been described to affect the progression of AD. This study investigated AD platelets with respect to density...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood properties and coagulation
Share to Parkinson's Disease Mechanisms and Treatments
Share to Restless Legs Syndrome Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22150375
DOI: 10.3109/09537104.2011.593654

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Low-density platelet populations demonstrate low<i>in vivo</i>activity in sporadic Alzheimer diseasePMID 22150375Read ↗

Potential links between platelets and amyloid-β in the pathogenesis of Alzheimer's disease: Evidence from in vitro, in vivo, and clinical studiesSemantic proximity Read ↗

Correlation analysis of peripheral platelet markers and disease phenotypes in Alzheimer's disease.Semantic proximity Read ↗

Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's disease.Semantic proximity Read ↗

Altered amyloid protein processing in platelets of patients with Alzheimer disease.Semantic proximity Read ↗

Pre-activated blood platelets and a pro-thrombotic phenotype in APP23 mice modeling Alzheimer's disease.Semantic proximity Read ↗

Increased apoptosis in the platelets of patients with Alzheimer’s disease and amnestic mild cognitive impairmentSemantic proximity Read ↗

Platelet hyperactivity in patients of vascular dementiaSemantic proximity Read ↗

ApoE genotype influences the biological effect of donepezil on APP metabolism in Alzheimer disease: evidence from a peripheral model.Semantic proximity Read ↗

Abnormal platelet amyloid-β protein precursor (AβPP) metabolism in Alzheimer's disease: identification and characterization of a new AβPP isoform as potential biomarker.Semantic proximity Read ↗

Inhibitory effects of in vivo oxidized high-density lipoproteins on platelet aggregation: evidence from patients with abetalipoproteinemia.Semantic proximity Read ↗

Apolipoprotein E genotype has no effect on the free intracellular Ca2+ concentration of platelets from Alzheimer's disease patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.